AUNA S.A. (AUNA): Financial results for Q2 2026
AUNA S.A. (AUNA) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Auna Announces 2Q26 Financial Results A consecutive quarter of strong top-line growth and cash flow performance; Consolidated Adjusted EBITDA impacted by service mix across the segments Luxembourg, August 18, 2026 – Auna (NYSE: AUNA) (“Auna” or the “Company”) , a lea
How this was made
The 30-second read
Why it matters
The earnings release provides fresh financial metrics and expansion updates that can influence stock valuation.
Market read
First report of Q2 2026 earnings for AUNA, offering actionable data for traders.
What to watch
Potential regulatory changes in Peru and Colombia and currency fluctuations may affect future results.
Background
Auna is a leading Latin American healthcare platform listed on NYSE, providing hospital and oncology services.
Ticker impact
Auna reported Q2 2026 results with revenue up 9% YoY and adjusted EBITDA down 9% YoY, plus guidance and operational updates.
Potential short-term volatility as investors digest mixed earnings; upside if guidance holds, downside if margin concerns dominate.
First disclosure of earnings with detailed numbers and operational outlook provides clear trading signals.
Market effects
Highlights growth and margin dynamics in Latin American healthcare sector.
Positive for regional markets in Mexico, Peru, Colombia as healthcare demand rises.
Limited to investors focused on emerging‑market healthcare exposure.
Counterpoint
Margin compression and service mix risks could outweigh revenue growth, suggesting a short bias.
Key entities
- ExecutiveAbraham Galán
New Chief Technology Officer appointed Aug 3 2026.




